ZHAO Hong-wen,YU Rong-jie,PENG Kan-fu,LIU Hong,WU Xiong-fei,HE Wei-feng,ZHANG Xiao-rong.Amelioration of Adriamycin nephropathy by transplanting endothelial progenitor cells transfected with Ad-VEGF165 gene[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(02):93-97.
ZHAO Hong-wen,YU Rong-jie,PENG Kan-fu,LIU Hong,WU Xiong-fei,HE Wei-feng,ZHANG Xiao-rong.Amelioration of Adriamycin nephropathy by transplanting endothelial progenitor cells transfected with Ad-VEGF165 gene[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(02):93-97.DOI:
Objective To construct the recombinant adenovirus of vascular endothelial growth factor 165 (Ad-VEGF
165
) and observe the effects of endothelial progenitor cells (EPCs) transfected with Ad-VEGF
165
gene on ameliorating renal damages induced with Adriamycin. Methods Ad-VEGF
165
was identified with polymerase chain reaction (PCR) and Western blot. EPCs derived from rat bone marrow were obtained b
y adherent culture for 6 days and transfected with Ad-VEGF
165
then injected into tail vein at the early stage of Adriamycin induced renal disease. Results PCR and Western blot indicated that the recombinant adenovirus contained the inserted VEGF
165
. The titer of the purified Ad-VEGF
165
was 1.4×10
10
pfu/ml. After transfection
the expression of VEGF protein was significantly higher than that of control and untransfected EPCs. The pathological changes were less in VEGF
165
transfecting group than that in untransfecting group at the 12
th
week
including glomerular sclerosis and tubulointerstitial fibrosis induced by Adriamycin after transplantation. Conclusion The Ad-VEGF
165
effectively mediates the target gene expression in cultured EPCs and ameliorates renal damages. But the adverse effect of VEGF to renal function needs further study.